Evidence map›Paper›PMID 41752379›Full record

ArticleMolecules (Basel, Switzerland)2026

Pd(II)-Prolinate Prolinium and Pd(II)-LysGly Complexes Catalyzed the Enantioselective Aldol, Morita-Baylis-Hillman and Heck Reactions.

Juan Carlos Jiménez-Cruz, Ramón Guzmán-Mejía, Verónica Cortés-Muñoz, Manuel Solís-Hernández, Hugo A García-Gutiérrez, Julio C Ontiveros-Rodríguez, Stephanie García-Zavala, Judit A Aviña-Verduzco

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Juan Carlos Jiménez-CruzSecretaria de Ciencia, Humanidades, Tecnologia e Innovación-Instituto de Investigaciones Químico Biológicas, Universidad Michoacana de San Nicolás de Hidalgo, Edificio B-1, Ciudad Universitaria, Morelia 58030, Michoacán, Mexico.ORCID 0000-0002-6527-9204
Ramón Guzmán-MejíaInstituto de Investigaciones Químico Biológicas, Universidad Michoacana de San Nicolás de Hidalgo, Av. Francisco J. Múgica, s/n, Edificio B-1, Ciudad Universitaria, Morelia 58030, Michoacán, Mexico.ORCID 0000-0001-6703-9995
Verónica Cortés-MuñozInstituto de Investigaciones Químico Biológicas, Universidad Michoacana de San Nicolás de Hidalgo, Av. Francisco J. Múgica, s/n, Edificio B-1, Ciudad Universitaria, Morelia 58030, Michoacán, Mexico.ORCID 0009-0004-8645-6419
Manuel Solís-HernándezInstituto de Investigaciones Químico Biológicas, Universidad Michoacana de San Nicolás de Hidalgo, Av. Francisco J. Múgica, s/n, Edificio B-1, Ciudad Universitaria, Morelia 58030, Michoacán, Mexico.ORCID 0000-0002-1678-0107
Hugo A García-GutiérrezInstituto de Investigaciones Químico Biológicas, Universidad Michoacana de San Nicolás de Hidalgo, Av. Francisco J. Múgica, s/n, Edificio B-1, Ciudad Universitaria, Morelia 58030, Michoacán, Mexico.ORCID 0000-0003-2841-0135
Julio C Ontiveros-RodríguezSecretaria de Ciencia, Humanidades, Tecnologia e Innovación-Instituto de Investigaciones Químico Biológicas, Universidad Michoacana de San Nicolás de Hidalgo, Edificio B-1, Ciudad Universitaria, Morelia 58030, Michoacán, Mexico.ORCID 0000-0002-1780-1854
Stephanie García-ZavalaInstituto de Investigaciones Químico Biológicas, Universidad Michoacana de San Nicolás de Hidalgo, Av. Francisco J. Múgica, s/n, Edificio B-1, Ciudad Universitaria, Morelia 58030, Michoacán, Mexico.ORCID 0009-0007-6750-3664
Judit A Aviña-VerduzcoInstituto de Investigaciones Químico Biológicas, Universidad Michoacana de San Nicolás de Hidalgo, Av. Francisco J. Múgica, s/n, Edificio B-1, Ciudad Universitaria, Morelia 58030, Michoacán, Mexico.ORCID 0000-0002-1266-5849

Funding

Coordinación de la Investigación Científica, Universidad Michoacana de San Nicolás de Hidalgo 19681, 18212
6 · The paper itself

Abstract

The induction of chirality to obtain enantiopure products of high synthetic value is of great importance across various scientific fields, particularly in the medical area, as it has been demonstrated that the different enantiomers of drugs interact differently with biological receptors. In this context, asymmetric catalysis focuses on the design of catalysts that are easy to synthesize, capable of efficiently and enantioselectively forming C-C bonds, and suitable for reuse in multiple catalytic processes. This work describes the application of a Pd(II) complex coordinated with the R and S forms of proline in direct Aldol, Morita-Baylis-Hillman, and Heck coupling reactions. The catalytic system efficiently promoted the aldol reaction, achieving yields of 80-95%, excellent diastereoselectivities (1:69

Indexed as

asymmetric synthesisC–C bonddipeptidepalladiumproline

Identifiers

PMID41752379
PMCPMC12943180

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.